Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor-Derived VSTs for Viral Prophylaxis Post-SCT
NCT03883906Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2019
- Primary completion
- Oct 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of viral-specific T-cells in viral infection, sponsored by Cincinnati Children's Hospital Medical Center. Started Mar 2019; status: completed.
02
Drugs
viral-specific T-cells
03
Conditions
viral infection
Beyond the preview
Go deeper on NCT03883906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883906.